Looking Back on 2025
The International Journal of Dermatology continues its long-standing commitment to global dermatologic health, with particular emphasis on neglected tropical diseases (NTDs) and the unique presentations of skin disease in people with skin of color [1, 2]. As we enter a new year, we remain deeply committed to strengthening diversity and equity within our field. We recognize the critical need for broader representation in dermatologic research, clinical trials, and educational resources, particularly regarding individuals with skin of color. As part of our mission, we will continue to publish papers that promote initiatives to ensure equitable dermatologic care for all patients, supporting a more inclusive and representative future for our specialty [3-5]. In 2025, the Journal received over 4500 submissions, a record that highlights both the vitality of our field and the truly international reach of our community. The largest number of submissions came from China, followed by the United States, India, Türkiye, and Italy, reflecting the broad participation and global relevance of dermatology research. We take considerable pride in serving as a platform where diverse clinical experiences—and the voices of authors from every region—converge. We also extend our appreciation to the authors whose work garnered the greatest interest in 2025. Table 1 presents the leading articles by full-text views, encompassing a range of topics such as frontal fibrosing alopecia, melasma pathogenesis, the biology of aging, exposure to UV/LED nail lamps, type 2 inflammation, psoriasis in skin of color, hidradenitis suppurativa during pregnancy, finasteride safety, toxicities associated with nail products, and long-term outcomes of keloid therapies. In addition to scientific advancements, 2025 marked ongoing progress in knowledge dissemination. We enhanced our monthly newsletters to provide succinct updates on significant publications and offer direct access to newly released content. To enhance the timely and accessible distribution of research, we provide concise summaries of all Open Access manuscripts. This ensures that significant findings, especially those with direct clinical implications, reach a wider audience and can be integrated into practice more efficiently. Our podcast series, which includes participation from Associate Editors, Junior Editors, and authors, has continued to develop, providing concise, expert-led discussions designed to keep readers informed about the latest evidence and developments. We also introduced a new manuscript section named Surgical Pearls. This feature highlights innovative approaches to complex surgical challenges across dermatologic surgery. We look forward to growing this series and inviting further submissions that share novel solutions, refinements, and technical wisdom. We released two special issues this year. One, guest-edited by Professor Andreas Wollenberg, emphasized the importance of basic emollients in managing dry skin and xerosis cutis. Another, edited by Professor Yang Bin and launched at the Chinese Dermatologist Association's 20th Annual Meeting in Chongqing, showcased advancements by Chinese dermatologists and garnered significant media attention with over 7 million impressions (Figure 1). We remain deeply grateful to the global dermatology community—our authors, reviewers, editorial board members, and readers. Your ongoing commitment strengthens the Journal and sustains our mission of promoting high-quality, inclusive, and globally relevant dermatologic research. We look forward to another year of collaboration, discovery, and shared progress in advancing skin health for all. The author has nothing to report. The author declares no conflicts of interest. The author has nothing to report.
Authors
- Lajos Vince Kemény (ORCID: https://orcid.org/0000-0002-2119-9501)
Institutions
- University of Szeged (HU)
Publication Details
- Journal
- International Journal of Dermatology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1111/ijd.70217
- Primary Topic
- Hidradenitis Suppurativa and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00